Drugs / MSDC-0602
last change Jun 2011 re-read 2 minutes ago

MSDC-0602

Developed for
type 2 diabetes mellitus
Investigated by
Metabolic Solutions Development Company

Trials 1 · a red edge is where a trial was stopped

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01280695 Feb → Jun 2011 type 2 diabetes mellitus Metabolic Solutions Development Company Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MSDC-0602 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01280695